FDA NDC Directory · JSON-LD · Markdown

BRILINTA

NDC 0186-0776 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameTicagrelor
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA022433
Dosage form / routeTABLET · ORAL
Active ingredientsTICAGRELOR (60 mg/1)
Marketing started20150904
Package count1

External sources

Source: openFDA. Public-domain (CC0).